North Star Investment Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$940 Hold
11
﹤0.01% 1497
2025
Q4
$917 Hold
11
﹤0.01% 1406
2025
Q3
$779 Hold
11
﹤0.01% 1183
2025
Q2
$700 Hold
11
﹤0.01% 1146
2025
Q1
$751 Hold
11
﹤0.01% 1132
2024
Q4
$696 Sell
11
-12
-52% -$826 ﹤0.01% 1165
2024
Q3
$1.59K Buy
23
+1
+5% +$70 ﹤0.01% 1097
2024
Q2
$1.49K Hold
22
﹤0.01% 1063
2024
Q1
$1.52K Buy
22
+1
+5% +$66 ﹤0.01% 1117
2023
Q4
$1.38K Hold
21
﹤0.01% 1084
2023
Q3
$1.3K Hold
21
﹤0.01% 1110
2023
Q2
$1.32K Hold
21
﹤0.01% 1115
2023
Q1
$1.29K Hold
21
﹤0.01% 1133
2022
Q4
$1.36K Hold
21
﹤0.01% 1128
2022
Q3
$1K Hold
21
﹤0.01% 1080
2022
Q2
$1K Hold
21
﹤0.01% 1085
2022
Q1
$1K Hold
21
﹤0.01% 1103
2021
Q4
$1K Hold
21
﹤0.01% 1130
2021
Q3
$1K Hold
21
﹤0.01% 1078
2021
Q2
$1K Hold
21
﹤0.01% 1055
2021
Q1
$1K Hold
21
﹤0.01% 1018
2020
Q4
$1K Hold
21
﹤0.01% 994
2020
Q3
$1K Buy
+21
New +$1.13K ﹤0.01% 974
2016
Q1
Sell
-300
Closed -$16K 766
2015
Q4
$16K Hold
300
﹤0.01% 527
2015
Q3
$15K Hold
300
﹤0.01% 536
2015
Q2
$17K Buy
+300
New +$17.5K ﹤0.01% 517

Other funds holding IHE

North Star Investment Management's IHE Position: Q1 2026 in Review

North Star Investment Management held its iShares US Pharmaceuticals ETF (IHE) position steady in Q1 2026 at 11 shares worth $940. The position accounts for ﹤0.01% of the portfolio, ranked #1497.

North Star Investment Management first reported a position in IHE in Q2 2015 and has held it in 26 quarters since. The position peaked at $17K in Q2 2015. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

  • North Star Investment Management held 11 shares of iShares US Pharmaceuticals ETF worth $940 as of Q1 2026.
  • North Star Investment Management left its iShares US Pharmaceuticals ETF share count unchanged in Q1 2026.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of North Star Investment Management's portfolio in Q1 2026, its #1497 holding.
  • North Star Investment Management first reported a position in iShares US Pharmaceuticals ETF in Q2 2015 and has held it in 26 quarters since.
  • North Star Investment Management's iShares US Pharmaceuticals ETF position peaked at $17K in Q2 2015.
  • 194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.